Notably, these data indicate Mdm2 levels did not broadly contribute to the type of sarcoma that emerged with the exception of Arf+/−p53+/− mice, but instead, Arf and p53 levels primarily dictated the sarcoma tumor subtype that developed. The gene discussed is TP53; the disease is neoplasm.